$ACMR

Wang David H sold $2.9M of ACMR

Wang David H (See Remarks) sold 32,450 shares of ACM Research, Inc. (ACMR) at $89.84 ($2.92M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

Traders may monitor for clustering of insider sales or subsequent buys, but this single disclosed sale (10b5-1) is typically not a standalone fundamental driver.

02

Market read

Routine insider selling disclosure; potential sentiment drag but limited actionable signal due to 10b5-1 pre-arrangement.

03

What to watch

Form 4 does not reveal intent beyond the plan; also, the post-transaction holdings remain substantial (819,663 shares), which can offset negative read-through.

Relevance 6/10Novelty 3/10Timing: Filed after-hours (2026-06-05) for a sale executed 2026-06-03

Background

SEC Form 4 insider transaction: officer/director/10% owner Wang David H sold shares on 2026-06-03; filing posted 2026-06-05.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACM Research insider David H. Wang sold 32,450 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low-to-moderate near-term overhang risk; directionally mixed and likely muted.

Evidence & confidence

The filing is a routine insider transaction and explicitly tied to a pre-arranged 10b5-1 plan, reducing the probability of new negative information.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide trigger.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • ACM Research, Inc.

    Issuer of the Form 4 insider sale disclosed in the article.

  • David H. Wang

    Officer/Director/10% owner who sold 32,450 shares under a pre-arranged 10b5-1 plan.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.